Showing results (321-330 of 439) with videos related to

Sort By:
Pageof 44
Blood Advances|November 23, 2020
Durable ibrutinib responses in relapsed/refractory marginal zone lymphoma: long-term follow-up and biomarker analysisAriela Noy, Sven de Vos, Morton Coleman, et al.
American Journal of Clinical Oncology|June 15, 2016
ACR Appropriateness Criteria® Hodgkin Lymphoma-Unfavorable Clinical Stage I and IIKenneth B Roberts, Anas Younes, David C Hodgson, et al.
Leukemia & Lymphoma|December 4, 2020
Nodular lymphocyte predominant Hodgkin lymphoma: executive summary of the American radium society appropriate use criteriaLeslie K Ballas, Monika L Metzger, Sarah A Milgrom, et al.
The Journal of Clinical Investigation|January 31, 2023
Cotargeting of BTK and MALT1 overcomes resistance to BTK inhibitors in mantle cell lymphomaVivian Changying Jiang, Yang Liu, Junwei Lian, et al.
American Journal of Clinical Oncology|September 20, 2016
ACR Appropriateness Criteria® Hodgkin Lymphoma-Favorable Prognosis Stage I and IISughosh Dhakal, Ranjana Advani, Leslie K Ballas, et al.
Journal of the American College of Radiology : JACR|October 4, 2014
ACR appropriateness criteria follow-up of Hodgkin lymphomaChul S Ha, David C Hodgson, Ranjana Advani, et al.
American Journal of Clinical Oncology|November 20, 2015
ACR Appropriateness Criteria® Diffuse Large B-Cell LymphomaBouthaina S Dabaja, Ranjana Advani, David C Hodgson, et al.
Pageof 44